Skip to main content

Pharmaceuticals Stocks, ETFs Could Have Power Beyond 2022

Pharmaceuticals stocks and the related exchange traded funds are benefiting from the now-steady revenue stream provided by coronavirus vaccines, but with that priced into many pharmaceuticals equities, analysts and investors are looking for more. Fortunately for investors considering ETFs such as...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.